{"id":"W2883187082","doi":"10.1016/j.cgh.2018.07.009","title":"Tofacitinib Induction Therapy Reduces Symptoms Within 3 Days for Patients With Ulcerative Colitis","year":2018,"lang":"en","type":"article","venue":"Clinical Gastroenterology and Hepatology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":185,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"Centre for Mathematical Cognition, Loughborough University; Ferring Pharmaceuticals; MedImmune; Eisai; Gilead Sciences; Celgene; Shire; AstraZeneca; Takeda Pharmaceuticals U.S.A.; School of Public Health, University of California Berkeley; Dr. Falk Pharma; Pfizer; Amgen; Celltrion; AbbVie; Schering-Plough; Meso Scale Diagnostics; Abbott Laboratories","keywords":"Tofacitinib; Medicine; Placebo; Ulcerative colitis; Internal medicine; Janus kinase inhibitor; Gastroenterology; Clinical endpoint; Randomized controlled trial; Rheumatoid arthritis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008814911,0.0003578405,0.0009719048,0.0002294544,0.0002095426,0.0002867256,0.0002178789,0.0002949802,0.001469373],"category_scores_gemma":[0.001908462,0.0001013499,0.0007359199,0.0002723148,0.000147872,0.0002681638,0.0001785823,0.0007617587,0.0001647137],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000306147,"about_ca_system_score_gemma":0.0004295155,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004718526,"about_ca_topic_score_gemma":0.001777876,"domain_scores_codex":[0.9996309,0.0001640811,0.00004236063,0.00003381086,0.0000715301,0.00005738289],"domain_scores_gemma":[0.9988465,0.0003375536,0.0004647914,0.00003571254,0.00007123662,0.0002442202],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.1436891,0.00894147,0.27204,0.001526922,0.002674942,0.0005044653,0.0004213601,0.001458204,0.02776618,0.0001007956,0.006622069,0.5342545],"study_design_scores_gemma":[0.0176158,0.0851887,0.8875414,0.0001571485,0.001150495,0.0007397979,0.0001420844,0.00109373,0.0027991,0.0001110178,0.003433724,0.00002696014],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9904287,0.007485357,0.0001401955,0.0003726985,0.00006279513,0.0001032703,0.0001878335,0.00003634632,0.001182768],"genre_scores_gemma":[0.9969325,0.001735974,0.0003635383,0.0002615539,0.00007957635,0.00006424855,0.0003087994,0.000003920966,0.0002497943],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001469373,"threshold_uncertainty_score":0.004915535,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01776128191355194,"score_gpt":0.2963944256288678,"score_spread":0.2786331437153159,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}